Cefotaxime breakpoint for Streptococcus pneumoniae
- 1 March 1993
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (3) , 616-617
- https://doi.org/10.1128/aac.37.3.616
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis.1992
- Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic useAntimicrobial Agents and Chemotherapy, 1992
- A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxoneAntimicrobial Agents and Chemotherapy, 1992
- Evaluation of vancomycin for therapy of adult pneumococcal meningitisAntimicrobial Agents and Chemotherapy, 1991
- Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics.1991
- Imipenem/cilastatin treatment of bacterial meningitis in childrenThe Pediatric Infectious Disease Journal, 1991
- Pneumococcal meningitis in a child with a ventriculo-peritoneal shuntJournal of Infection, 1991
- Antibiotic concentrations in liquor compared to the minimal inhibitory concentrations of isolates in paediatric bacterial meningitis. The Finnish Study Group.1991
- Bacterial Meningitis: Recent Advances in Pathophysiology and TreatmentAnnals of Internal Medicine, 1990
- Cefotaxime in the cerebrospinal fluid and serum in patients with purulent meningitisJournal of Antimicrobial Chemotherapy, 1984